The efficacy and safety of Chinese herbal medicine Guizhi Fuling capsule combined with low dose mifepristone in the treatment of uterine fibroids: a systematic review and meta-analysis of 28 randomized controlled trials.

Lei, Yiming; Yang, Lili; Yang, Honglian; Li, Min; Ou, Li; Bai, Yang; Dong, Taiwei; Gao, Feng; Wei, Peifeng

Lei, Yiming; Yang, Lili; Yang, Honglian; Li, Min; Ou, Li; Bai, Yang; Dong, Taiwei; Gao, Feng; Wei, Peifeng.

Afiliação

Lei Y; Shaanxi University of Chinese Medicine, Xianyang, China.
Yang L; Shaanxi University of Chinese Medicine, Xianyang, China.
Yang H; The Second Affiliated Hospital of Shaanxi University of Chinese Medicine, Xianyang, China.
Li M; Shaanxi University of Chinese Medicine, Xianyang, China.
Ou L; Shaanxi University of Chinese Medicine, Xianyang, China.
Bai Y; The Second Affiliated Hospital of Shaanxi University of Chinese Medicine, Xianyang, China.
Dong T; Shaanxi University of Chinese Medicine, Xianyang, China.
Gao F; Shaanxi University of Chinese Medicine, Xianyang, China. 7204612@qq.com.
Wei P; The Second Affiliated Hospital of Shaanxi University of Chinese Medicine, Xianyang, China. weipeifeng@163.com.

BMC Complement Med Ther ; 23(1): 54, 2023 Feb 18.

Article em En | MEDLINE | ID: mdl-36803997

Assuntos

Medicamentos de Ervas Chinesas; Leiomioma; Wolfiporia; Feminino; Humanos; Mifepristona/uso terapêutico; Medicamentos de Ervas Chinesas/efeitos adversos; Ensaios Clínicos Controlados Aleatórios como Assunto; Leiomioma/tratamento farmacológico

Palavras-chave

Guizhi Fuling capsule; Meta-analysis; Mifepristone; Systematic review; Uterine fibroids

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Medicamentos de Ervas Chinesas / Wolfiporia / Leiomioma Tipo de estudo: Clinical_trials / Systematic_reviews Limite: Female / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google